期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 896, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2021.173914
关键词
miRNA; lncRNA; Parkinson's disease
资金
- Shahid Beheshti University of Medical Sciences
Parkinson's disease is a neurodegenerative disorder that causes motor abnormalities in middle-aged and elderly individuals, with clinical signs including bradykinesia, rigidity, and resting tremor. Dysregulation of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in brain tissues, plasma exosomes, and leukocytes has been implicated in the pathogenesis of PD.
Parkinson's disease (PD) is the second main neurodegenerative disease causing motor abnormalities in the middle-aged and old individuals. In some cases, cognitive dysfunction also occurs. The clinical signs of PD are bradykinesia, rigidity and resting tremor. As these signs might be detected in other neurological conditions such as multiple systems atrophy and corticobasal degeneration, it is necessary to find specific and sensitive markers for this disorder. Non-coding RNAs are implicated in the different PD-associated features such as a-synuclein expression and Lewy body construction, mitochondrial dysfunction, apoptosis, neuroinflammation and defects in glial cell-derived neurotrophic factor. Several researches have confirmed dysregulation of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in brain tissues, plasma exosomes and leukocytes of affected individuals or animal models of PD. A number of these transcripts directly regulate the neurodegenerative process in PD. In the current study, we review the current data about dysregulation of ncRNAs and the role of their genomic variants in the pathogenesis of PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据